BTRL was founded in August of 2006 with the overall mission to provide viable solutions to the treatment of degenerative diseases, focusing on cardiovascular and orthopedic systems. Read More
Recent News

"Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy," edited by Dr. Simionescu, has reached 20,000 downloads on InTech Publishing.

Due to the potential threat of COVID-19, the March 2020 Dempsey Research Conference has been cancelled.

We will be looking into rescheduling for Fall 2020 or Spring 2021. More details to follow. Please contact Dan Simionescu or Kevin Taaffe with any questions.

Drs. Dan and Agneta Simionescu, along with Clemson colleague, Dr. Christopher DeBorde, serve as Guest Editors for a Special Issue of Bioengineering, "Mesenchymal Stem Cells in Tissue Regeneration." For more information, please visit this Special Issue page on MDPI Open Access.

Drs. Dan and Agneta Simionescu were recently featured in an article of the Spring 2018 BIOE bulletin. Please click here to view the bulletin; the article: Working for the Betterment of Patients' Lives Worldwide: Dan and Aggie Simionescu can be found on pages 9-10.

More News   Quick Links

 Clemson Bioengineering